Monoclonal antibody G250RIT
Alternative Names: WX-G250RITLatest Information Update: 20 Nov 2017
At a glance
- Originator Centocor
- Developer Wilex
- Class Monoclonal antibodies; Radiopharmaceuticals; Radiosensitisers
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Biliary cancer; Renal cancer
Most Recent Events
- 26 Jun 2003 Phase-I/II clinical trials in Biliary cancer in Netherlands (IV)
- 22 Apr 2002 Phase-II clinical trials in Renal cancer in Germany (IV)
- 22 Apr 2002 Preclinical trials in Biliary cancer in Germany (IV)